ReviewViruses2024

3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials.

Vitor Martins de Freitas Amorim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.